Jazz Pharmaceuticals (JAZZ)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

123.04

0.03%

After-hours Dec 13, 2024, 05:19 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04
Revenue	3.83B	3.66B	3.09B	2.36B	2.16B	1.89B	1.62B	1.49B	1.32B	1.17B	872.42M	585.98M	272.28M	173.78M	128.45M	67.51M	65.30M	44.86M	21.44M	-
Cost of Revenue	435.58M	540.52M	440.76M	148.92M	127.93M	121.54M	110.19M	105.39M	102.53M	117.42M	102.15M	78.42M	13.94M	13.56M	9.64M	13.92M	8.90M	6.97M	4.29M	-
Gross Profit	3.40B	3.12B	2.65B	2.21B	2.03B	1.77B	1.51B	1.38B	1.22B	1.06B	770.28M	507.55M	258.33M	160.22M	118.81M	53.59M	56.40M	37.89M	17.15M	-
Operating Income	578.58M	512.27M	170.28M	765.46M	532.37M	614.84M	528.84M	591.65M	508.22M	195.59M	340.31M	197.84M	127.83M	57.79M	15.93M	-170.37M	-138.78M	-78.05M	-78.44M	-24.80M
Interest Income	-	11.50M	1.80M	99.71M	20.50M	-	-	-	-	-	-	-	75.00K	6.00K	34.00K	1.83M	-	-	-	-
Pretax Income	297.93M	-372.78M	-112.84M	275.10M	454.30M	529.46M	441.12M	532.45M	435.93M	151.56M	307.95M	177.35M	124.98M	32.78M	-6.84M	-184.34M	-138.83M	-47.57M	-100.64M	-
Net Income	414.83M	-214.14M	-328.95M	238.62M	523.37M	447.10M	487.85M	396.83M	329.54M	58.39M	216.31M	288.59M	124.98M	32.78M	-6.84M	-184.34M	-138.83M	-59.39M	-85.16M	-24.80M
Selling & General & Admin	1.34B	1.42B	1.45B	854.23M	736.94M	683.53M	544.16M	502.89M	449.12M	406.11M	304.30M	223.88M	108.94M	69.00M	58.65M	111.40M	78.54M	51.38M	23.55M	-
Research & Development	849.66M	590.45M	505.75M	335.38M	299.73M	226.62M	198.44M	162.30M	135.25M	85.18M	46.62M	20.48M	14.12M	25.61M	36.56M	69.96M	69.79M	54.96M	45.78M	-
Other Expenses	627.28M	599.17M	525.77M	259.58M	354.81M	201.50M	152.06M	101.99M	98.16M	126.58M	79.04M	65.35M	7.45M	7.83M	7.67M	12.83M	46.85M	9.60M	4.96M	-24.80M
Operating Expenses	2.82B	2.61B	2.48B	1.45B	1.39B	1.11B	894.66M	767.18M	682.53M	617.88M	429.96M	309.71M	130.50M	102.43M	102.88M	194.19M	195.18M	115.94M	74.29M	-24.80M
Interest Expense	289.44M	288.24M	278.77M	99.71M	72.26M	77.08M	77.76M	61.94M	56.92M	52.71M	26.92M	16.87M	1.68M	12.73M	22.80M	19.74M	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	25.70M	1.00M	700.00K	-	-	-	-	-	-	-	-
Cost & Expenses	3.26B	3.15B	2.92B	1.60B	1.52B	1.23B	1.00B	872.57M	785.06M	735.30M	532.11M	388.13M	144.45M	115.99M	112.52M	208.12M	204.08M	122.91M	78.59M	-24.80M
Income Tax	-119.91M	-158.65M	216.12M	33.52M	-73.15M	80.16M	-47.74M	135.24M	106.40M	94.23M	91.64M	-83.79M	2.85M	25.01M	22.77M	43.74M	48.00K	-18.66M	28.01M	24.80M
Shares Outstanding (Basic)	63.29M	62.54M	59.69M	55.71M	56.75M	59.98M	60.02M	60.50M	61.23M	59.75M	58.30M	56.64M	41.50M	36.34M	30.02M	25.65M	13.83M	13.47M	13.47M	13.47M
Shares Outstanding (Diluted)	72.07M	62.54M	59.69M	56.52M	57.55M	61.22M	61.32M	61.87M	63.04M	62.61M	61.57M	60.20M	46.80M	39.41M	30.02M	25.65M	13.83M	13.47M	13.47M	13.47M
EPS (Basic)	6.95	-3.42	-5.51	4.28	9.22	7.45	8.13	6.56	5.38	0.98	3.71	5.09	3.01	0.90	-0.23	-7.19	-10.04	-4.41	-6.32	-1.84
EPS (Diluted)	6.10	-3.42	-5.51	4.22	9.09	7.30	7.96	6.41	5.23	0.93	3.51	4.79	2.67	0.83	-0.23	-7.19	-10.04	-4.41	-6.32	-1.84
EBITDA	1.29B	553.78M	1.03B	649.65M	1.01B	932.66M	779.00M	753.88M	665.97M	583.70M	454.11M	268.45M	136.91M	54.22M	15.93M	-125.58M	-128.25M	-67.74M	-51.70M	-24.80M
Depreciation & Amortization	638.70M	629.47M	552.48M	278.25M	370.16M	216.73M	165.15M	113.78M	98.16M	126.58M	82.09M	74.23M	7.83M	7.83M	7.67M	15.03M	10.53M	10.31M	5.44M	-